Testing a new drug in healthy volunteers
This study tests a new medicine called HH-1270 in healthy volunteers to see if it is safe and how the body handles it. It is the first time this drug is being tested in humans, and the results will help decide future studies in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in generally good health, with no major illnesses.
- Your weight is within a certain range (men at least 50 kg, women at least 45 kg, with a BMI between 18 and 28).
- You are willing to use effective birth control during the study (if you could become pregnant or get someone pregnant).
- You have not used certain medications, drugs, or alcohol recently, and you do not smoke or use nicotine products often.
- You are willing to stay at the study site and follow a controlled diet during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This study looks at people in China who have hepatitis D, a liver infection. It aims to learn more about the disease and how it affects people, which may help improve future care.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
Hear when a new Chronic HDV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.